Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alan M. Seddon
Co-Expression and Prognostic Significance of Putative CSC Markers CD44, CD133, Wild-Type EGFR and EGFRvIII in Metastatic Colorectal Cancer
Oncotarget
Oncology
Related publications
Prognostic Significance of CD133 and Ezrin Expression in Colorectal Carcinoma
IUBMB Life
Biochemistry
Genetics
Clinical Biochemistry
Cell Biology
Molecular Biology
Evaluation of CD44 and CD133 as Cancer Stem Cell Markers for Colorectal Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Co-Expression of CD133+/CD44+in Human Colon Cancer and Liver Metastasis
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy
Cancers
Cancer Research
Oncology
Prognostic Significance of TRAIL-R1 and TRAIL-R3 Expression in Metastatic Colorectal Carcinomas
European Journal of Cancer
Cancer Research
Oncology
FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Prognostic Significance of CD44 Expression in Adenocarcinoma of the Lung
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Clinical Significance of HER2 and EGFR Expression in Colorectal Cancer Patients With Ovarian Metastasis
BMC Clinical Pathology
Forensic Medicine
Pathology
Histology
P009 to Investigate the Prognostic Factors and the Significance of TKI in Advanced NSCLC With Wild-Type EGFR
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary